- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Marapharm Ventures Begins Trading on The OTCQX Exchange
Marapharm Ventures announced shares of its common stock began trading on the OTCQX Best Market.
Marapharm Ventures (CSE:MDM; OTCQX:MRPHF) announced shares of its common stock began trading on the OTCQX Best Market.
As quoted in the press release:
Marapharm will continue to trade in Canada on the CSE and in Europe on the FSE.
Marapharm is a company that invests in medical and legal adult-use recreational cannabis. Its operations are strategically located in Las Vegas, Nevada, California, Washington and Canada.
“The Marapharm team embodies the entrepreneurial spirit and has great synergy, made up of individuals with backgrounds in finance, law, marketing, cannabis cultivation, plant extraction, government regulation and business startup expertise,” said Linda Sampson CEO Marapharm Ventures.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.